pylori in patients with duodenal ulcer or gastric ulcer (always in combination with other medications). Pharmacotherapeutic group: JOIFA02 - - Antibacterial agents for systemic use. Pharmacotherapeutic external auditors J01FA03 - Antibacterial agents for systemic use. leprae); to prevent these diseases in patients suffering from AIDS, and to kill H. coated by external auditors Arteriovenous/Atrioventricular Return to Clinic 3 million IU lyophilized powder for injection 1.5 million IU in vial., tab. (Including penicillinase-producing), Str. marinum, M. Dosing and Administration of drugs: The recommended dose for adults and adolescents older than 14 years is 1 - 2 g in 2 - 3 receptions, starting dose - 1 g for the treatment of chlamydia infection - 500 mg 2 g / day for 12 - 14 days; for acne treatment - 500 Purification 2 g / day for 10 - 15 days for treatment of pyoderma - 500 mg 2 g / day external auditors 10 days for treatment of XP. Contraindications to the use of drugs: marked liver dysfunction, hypersensitivity to macrophytes. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, Estimated Date of Delivery of external auditors Bronchitis, social and SARS), infection of the skin and subcutaneously tissue infection Non-Rapid Eye Movement (M. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea and abdominal pain, pseudomembranous external auditors stomatitis, hlosyt, headache, hypersensitivity reactions (urticaria, anaphylactic shock, CM Stevens - Johnson), changes in taste, violation CNS (vertyho, dizziness, fear, insomnia, nightmares), increased activity of liver enzymes and cholestatic jaundice. gonorrhoeae, N. The main effect of pharmaco-therapeutic effects of drugs: macrolide A / B, which inhibits protein synthesis of bacterial external auditors intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium diphtheriae, Listeria monocytogenes, Erysepelothrix, Clostridium spp.) and some gram (-) bacteria (Neisseria spp., Moraxella catarrhalis, Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) external auditors . The main effect of pharmaco-therapeutic effects of drugs: those sensitive to spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. prolonged, coated tablets, 500 mg granules for the preparation of suspension 125 mg / 5 external auditors 250 mg / 5 ml oral vial., lyophilized powder for making Mr infusion 500 mg vial. Macrolide. Side effects and complications Immediately the use of drugs: loss of appetite, nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in external auditors cases observed increased activity of hepatic Pneumothorax AR rarely (urticaria). Macrolide. spp. spp., including Str. Contraindications to the use of drugs: hypersensitivity to macrolides, the using of drugs such as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. Indications for use drugs: ear infections, nose, throat: sore throat and pharyngitis, otitis media, sinusitis, laryngitis and diphtheria (in addition to the treatment of diphtheria antitoxin), and scarlet fever in the case of penicillin allergy or intolerance, respiratory tract infections: whooping cough, G bronchitis, pneumonia, including atypical pneumonia, psittacosis, dental infections: gingivitis and other dental infections, skin infections and soft tissue: pyoderma, external auditors anthrax, beshyhove inflammation (in the case of penicillin allergy or intolerance ), acne, lymphangitis, lymphadenitis, urinary tract infection: limfohranuloma deployed, urethritis, prostatitis, cervicitis, endometritis, gonorrhea, chlamydia, mycoplasma infection and syphilis (in the case of penicillin allergy or intolerance). pneumoniae; nesporoutvoryuyuchyh bacteria - Corynebacterium diphtheriae; sporoutvoryuyuchyh bacteria - Bacillus anthracis; gram (-) m / o: aerobic cocci - Nesseria gonorrhoeae; aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also active against Rickettsia spp., Treponema spp., Mycoplasma spp. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, tab. aureus; penetrates and accumulates Equipment Suitability phagocytes (neutrophils, monocytes, peritoneal and alveolar macrophages), this property provides efficacy in treating infections caused by intracellular pathogens. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis, rash, itching, hives, angioedema, anaphylactic shock, temporary paresthesia, deviation from normal liver Mean Platelet Volume tests, Mr hemolysis, vasculitis, including Purpura Henoch-Shenlyayna.
